(HALO) Halozyme Therapeutics - Performance 52.8% in 12m
Compare HALO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
60.37%
#8 in Group
Rel. Strength
90.30%
#775 in Universe
Total Return 12m
52.75%
#27 in Group
Total Return 5y
151.70%
#15 in Group
P/E 17.1
50th Percentile in Group
P/E Forward 12.7
46th Percentile in Group
PEG -2.50
13th Percentile in Group
FCF Yield 5.73%
98th Percentile in Group
12m Total Return: HALO (52.8%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: HALO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HALO
Total Return (including Dividends) | HALO | XBI | S&P 500 |
---|---|---|---|
1 Month | -2.97% | 5.55% | -0.45% |
3 Months | 6.66% | -9.75% | -6.29% |
12 Months | 52.75% | -5.39% | 13.04% |
5 Years | 151.70% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | HALO | XBI | S&P 500 |
1 Month | -7.30% | 70% | 47.5% |
3 Months | 47.7% | -88.1% | -87.3% |
12 Months | 51.2% | -44.4% | 54.3% |
5 Years | 51.4% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #139 | -8.08% | -2.54% |
3 Month | #40 | 18.2% | 13.8% |
12 Month | #28 | 61.5% | 35.1% |
5 Years | #15 | 190% | 18.8% |
FAQs
Does HALO Halozyme Therapeutics outperforms the market?
Yes,
over the last 12 months HALO made 52.75%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months HALO made 6.66%, while XBI made -9.75%.
Over the last 3 months HALO made 6.66%, while XBI made -9.75%.
Performance Comparison HALO vs Indeces and Sectors
HALO vs. Indices HALO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.83% | -2.52% | 6.62% | 39.7% |
US NASDAQ 100 | QQQ | -1.75% | -4.87% | 5.91% | 37.8% |
US Dow Jones Industrial 30 | DIA | -0.29% | -0.12% | 7.38% | 43.5% |
German DAX 40 | DAX | -0.47% | -2.75% | -11.5% | 27.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.82% | 0.24% | 10.3% | 47.8% |
Hongkong Hang Seng | HSI | -0.43% | -1.45% | 6.09% | 39.8% |
India NIFTY 50 | INDA | 1.69% | -7.85% | 6.74% | 49.9% |
Brasil Bovespa | EWZ | 0.80% | -5.80% | 0.92% | 59.5% |
HALO vs. Sectors HALO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.98% | -2.37% | 0.64% | 29.3% |
Consumer Discretionary | XLY | -0.86% | -2.38% | 5.45% | 38.1% |
Consumer Staples | XLP | 1.23% | -2.15% | 2.52% | 41.8% |
Energy | XLE | 3.43% | 11.1% | 11.8% | 62.1% |
Financial | XLF | 0.28% | -0.96% | -0.31% | 30.1% |
Health Care | XLV | 1.87% | 1.70% | 11.8% | 54.0% |
Industrial | XLI | -1.15% | -3.27% | 5.58% | 42.1% |
Materials | XLB | 0.98% | 0.25% | 14.5% | 57.2% |
Real Estate | XLRE | -0.72% | -1.87% | 6.46% | 34.4% |
Technology | XLK | -2.39% | -5.40% | 9.57% | 42.3% |
Utilities | XLU | 0.45% | -3.07% | 2.20% | 32.0% |
Aerospace & Defense | XAR | -1.86% | -9.95% | -7.26% | 25.3% |
Biotech | XBI | -0.67% | -8.52% | 21.9% | 58.1% |
Homebuilder | XHB | 0.44% | -0.89% | 21.6% | 58.9% |
Retail | XRT | 0.41% | -1.81% | 12.6% | 54.3% |